News ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-24 pm EDT			5-day change	1st Jan Change
11.03 ^USD	+0.91%		-0.85%	+79.35%

Jul. 09	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 15	ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026

All News

Mentions Relevance

Jul. 09	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026	CI
Jul. 09	ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results	AQ
May. 15	ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026
May. 14	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
May. 14	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 08	ImmuCell, Norbrook enter settlement deed on May 8, 2026 - SEC filing	RE
May. 07	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
Apr. 22	ImmuCell : Corporate Presentation (Investor Relations April 2026 Final)	PU
Apr. 13	ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors	AQ
Apr. 13	ImmuCell Corporation Announces Board Changes	CI
Apr. 08	ImmuCell Q1 Sales Jump; Shares Rise After Hours	MT
Apr. 08	ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results	AQ
Apr. 08	Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Firs Quarter of 2026	CI
Mar. 18	Immucell Corporation Announces Changes to Its Board, Effective April 1, 2026	CI
Mar. 18	ImmuCell : 03-18-26 – ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	PU
Mar. 18	ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	AQ
Mar. 05	ImmuCell Corporation, Q4 2025 Earnings Call, Mar 05, 2026
Mar. 04	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Mar. 04	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025	AQ
Feb. 18	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025	AQ
Feb. 09	Steven A. Rosgen and Bryan K. Gathagan Have Decided Not to Seek Re-Election as Directors of ImmuCell Corporation	CI
Jan. 09	ImmuCell Corporation, Q4 2025 Sales/ Trading Statement Call, Jan 09, 2026
Jan. 08	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025	AQ
Jan. 08	Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Jan. 07	ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus	AQ